CrowdStrike vs BioCatch

By valuation, CrowdStrike is the larger company at $107B versus $1.3B — a 82.3x difference. Size can also be measured by team: CrowdStrike employs 9000 people while BioCatch has 100-500 employees.

BioCatch has raised $213M in disclosed funding across 1 known round. CrowdStrike's funding history is not publicly available.

CrowdStrike leads with an Awaira Score of 92/100, while BioCatch sits at 80/100. That 12-point gap reflects real differences in funding, scale, and traction — it's not a vanity metric.

CrowdStrike was founded by George Kurtz in 2011. BioCatch was founded by Avi Turgeman in 2011. Visit each company's profile on Awaira for a full founder biography.

CrowdStrike: CrowdStrike is a publicly traded cybersecurity company founded in 2011 that specializes in cloud-native endpoint protection and threat intelligence. The company's core platform, the Falcon suite, uses artificial intelligence and machine learning to detect, prevent, and respond to cyber threats across endpoints, cloud workloads, and identity systems. CrowdStrike's approach centers on behavioral analysis and AI-driven threat hunting rather than signature-based detection alone. The company serves enterprise customers across financial services, healthcare, technology, and government sectors. Its platform integrates endpoint detection and response (EDR), managed threat hunting, vulnerability management, and security analytics. CrowdStrike has maintained significant market position through continuous product expansion and acquisitions that enhance its capabilities. With a valuation of $107.0 billion, CrowdStrike is among the most valuable cybersecurity firms globally. The company competes directly with Microsoft Defender for Endpoint, Palo Alto Networks, SentinelOne, and other endpoint security providers. Its growth trajectory has been supported by increasing enterprise adoption of cloud-based security solutions and the growing demand for AI-enhanced threat detection. CrowdStrike generates revenue through subscription-based licensing models, with customers deploying the platform across thousands of endpoints. The company has achieved profitability and continues expanding internationally while investing in artificial intelligence capabilities for predictive threat intelligence. CrowdStrike pioneered cloud-native endpoint protection at scale, differentiating itself through AI-driven behavioral analysis rather than legacy signature-based detection methods. BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection.

Both CrowdStrike and BioCatch launched in 2011. Same year, but even a few months' head start matters in AI — early movers lock in data, talent, and customer relationships fast.

CrowdStrike has about 9000 employees; BioCatch has about 100-500. A bigger team usually means more revenue or heavier VC backing, but in AI, small teams can build at massive scale.

Yes — they're direct rivals. Both CrowdStrike and BioCatch compete in AI Security, targeting many of the same buyers. If you're evaluating one, you should be looking at the other.